| Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals |
12 |
| Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers |
11 |
| A review of approaches to F-18 radiolabelling affinity peptides and proteins |
10 |
| Recent progress in [C-11]carbon dioxide ([C-11]CO2) and [C-11]carbon monoxide ([C-11]CO) chemistry |
8 |
| Hypervalent aryliodine compounds as precursors for radiofluorination |
7 |
| Automated synthesis of PET radiotracers by copper-mediated F-18-fluorination of organoborons: Importance of the order of addition and competing protodeborylation |
7 |
| Ra-224 labeling of calcium carbonate microparticles for internal -therapy: Preparation, stability, and biodistribution in mice |
7 |
| Recent developments in carbonylation chemistry using [C-13]CO, [C-11]CO, and [C-14]CO |
7 |
| Dual-time-point Cu-64-PSMA-617-PET/CT in patients suffering from prostate cancer |
7 |
| PET radiometals for antibody labeling |
6 |
| Aligning physics and physiology: Engineering antibodies for radionuclide delivery |
6 |
| Zr-89-ImmunoPET companion diagnostics and their impact in clinical drug development |
6 |
| In-loop [C-11]CO2 fixation: Prototype and proof of concept |
6 |
| Exendin-4 analogs in insulinoma theranostics |
6 |
| Evaluation of a P,N-ligated iridium(I) catalyst in hydrogen isotope exchange reactions of aryl and heteroaryl compounds |
6 |
| Development of novel radionuclides for medical applications |
5 |
| Synthesis, bioconjugation and stability studies of [F-18]ethenesulfonyl fluoride |
5 |
| Indium-111 labeling of high-density lipoprotein-mimicking phospholipid-styrene maleic acid copolymer complexes and its biodistribution in mice |
5 |
| Automated production of [F-18]FTHA according to GMP |
5 |
| New trends and applications in carboxylation for isotope chemistry |
5 |
| Theranostic CAR T cell targeting: A brief review |
5 |
| Radioimmunotherapy of solid tumors: Approaches on the verge of clinical application |
5 |
| Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapyModel, vector, and radionuclide selection |
4 |
| Astatine |
4 |
| Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors |
4 |
| Synthesis of carbon-14 labeled ketamine and norketamine |
4 |
| Lu-177-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell line |
4 |
| Practical microscale one-pot radiosynthesis of F-18-labeled probes |
4 |
| Radiometals for imaging and theranostics, current production, and future perspectives |
4 |
| Design and development of the theranostic pair Lu-177-OPS201/Ga-68-OPS202 for targeting somatostatin receptor expressing tumors |
4 |
| Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples |
4 |
| Development and radiosynthesis of the first F-18-labeled inhibitor of monocarboxylate transporters (MCTs) |
4 |
| Synthesis and evaluation of an F-18-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography |
3 |
| An azeotropic drying-free approach for copper-mediated radiofluorination without addition of base |
3 |
| Facile radiolabeling optimization process via design of experiments and an intelligent optimization algorithm: Application for omeprazole radioiodination |
3 |
| Minimalist approach meets green chemistry: Synthesis of F-18- labeled (hetero)aromatics in pure ethanol |
3 |
| Synthesis and pharmacological evaluation of fluorinated benzo[7]annulen-7-amines as GluN2B-selective NMDA receptor antagonists |
3 |
| A novel synthesis of 6 ''-[F-18]-fluoromaltotriose as a PET tracer for imaging bacterial infection |
3 |
| An efficient new method for the synthesis of 3-[F-18]fluoro-4-aminopyridine via Yamada-Curtius rearrangement |
3 |
| Tc-99m-labeled oligomeric nanoparticles as potential agents for folate receptor-positive tumor targeting |
3 |
| Automated GMP-production of alpha-[C-11]methyl-L-tryptophan using a tracer production system (TPS) |
3 |
| Improved, one-pot synthesis of 6-[F-18]fluorodopamine and quality control testing for use in patients with neuroblastoma |
3 |
| Development of single vial kits for preparation of Ga-68-labelled hexavalent lactoside for PET imaging of asialoglycoprotein receptor |
3 |
| Preclinical evaluation of potential infection-imaging probe [Ga-68]Ga-DOTA-K-A9 in sterile and infectious inflammation |
3 |
| Radiosynthesis of microtubule-targeted theranostic methyl N-[5-(3'-radiohalobenzoyl)-1H-benzimidazol-2-yl]carbamates |
3 |
| Synthesis and biological evaluation of deuterated sofosbuvir analogs as HCV NS5B inhibitors with enhanced pharmacokinetic properties |
3 |
| Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor |
3 |
| In-loop flow [C-11]CO2 fixation and radiosynthesis of N,N-[C-11]dibenzylurea |
3 |
| Recent progress using the Staudinger ligation for radiolabeling applications |
3 |
| Targeted Cu-64-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging |
3 |
